# A Study of LY2624803 in Participants With Transient Insomnia

> **NCT01779830** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 32 (actual)

## Conditions studied

- Transient Insomnia

## Interventions

- **DRUG:** LY2624803 - Capsules
- **DRUG:** Zolpidem - Tablets
- **DRUG:** Placebo - Capsules
- **DRUG:** Placebo - Tablets

## Key facts

- **NCT ID:** NCT01779830
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2013-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01779830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01779830, "A Study of LY2624803 in Participants With Transient Insomnia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01779830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*